Minirin (Desmopressin Acetate)

Desmopressin acetate, the active ingredient in Minirin, is a vasopressin (antidiuretic hormone) analog presented as a tablet for oral use. It selectively stimulates renal V2 receptors, increasing water reabsorption to treat central diabetes insipidus, primary nocturnal enuresis in children, and nocturnal polyuria.

GNH USA supplies Minirin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from regulatory compliance and consistent product availability.

Desmopressin acetate (Minirin) acts on the antidiuretic pathway to manage conditions characterized by excessive urine production. - Central diabetes insipidus: reduces polyuria by enhancing water reabsorption in the kidneys. - Primary nocturnal enuresis (bedwetting) in children: decreases nighttime urine output, helping achieve dry nights. - Nocturnal polyuria: lowers excessive nighttime urine volume, improving sleep quality.

Desmopressin acetate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea: occasional gastrointestinal upset. - Abdominal cramps: mild discomfort. - Nasal congestion: transient stuffiness. - Mild hyponatremia: low sodium without severe symptoms. - Flushing: temporary skin redness.

Serious or Rare Side Effects: - Severe hyponatremia: can lead to seizures or coma. - Water intoxication: excessive fluid retention causing cerebral edema. - Allergic reactions: rash, itching, or anaphylaxis. - Hypotension: marked drop in blood pressure.

Before prescribing Minirin, clinicians should consider several precautionary measures to ensure safe use. - Assess fluid balance: monitor patient’s fluid intake and output. - Check serum sodium: evaluate baseline sodium levels and repeat during therapy. - Adjust dose in renal impairment: reduce dosage in patients with reduced kidney function. - Avoid concomitant antidiuretics: do not combine with other V2‑stimulating agents. - Caution in elderly: increased susceptibility to hyponatremia; monitor closely. - Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Desmopressin acetate can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Other antidiuretic agents (e.g., chlorpropamide): may cause dangerous hyponatremia. - Vasopressin antagonists (vaptans): block V2 receptors and reduce therapeutic effect. - NSAIDs (e.g., ibuprofen): can potentiate water retention and hyponatremia risk.

Moderate Interactions (Monitor Closely): - Carbamazepine: increases metabolism of desmopressin, lowering its effectiveness. - SSRIs (e.g., fluoxetine): may enhance risk of hyponatremia. - Warfarin: desmopressin may affect bleeding time; monitor INR.